Bridging the Gap, Accelerating the Path to Cure with Strategic Funding Solutions

Sabine Hutchison talks to the inspiring investor Stephanie Oestreich.

In the first episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by the inspiring Stephanie Oestreich, whose work at the Myeloma Investment Fund (MIF) involves applying financial investment, scientific knowledge and valuable connections to reach a cure for every single Myeloma patient.

At MIF, Stephanie uses the investment and drug development knowledge and skills she has gained in several leadership roles in biotech and big pharma.

In this engaging conversation, Sabine talks to Stephanie about the challenges involved in running a specialty fund, and what she looks for in potential investments. Stephanie shares that MIF’s North Star is finding a cure for patients, and why it’s valuable for investor ...